Top Fund Managers Reveal Six Undervalued Stocks Poised for Growth

Six prominent fund managers, overseeing billions in assets, have identified companies they believe are undervalued and positioned for substantial growth. These selections range from established pharmaceutical giants to emerging financial services firms, each offering unique investment opportunities.

Stephen Yiu, manager of the Blue Whale Growth fund, which has delivered an average annual return of 19.2 percent since its inception, is enthusiastic about U.S. pharmaceuticals company Eli Lilly. Yiu's investment strategy focuses on companies capturing significant spending from consumers, enterprises, and governments. Eli Lilly, he notes, is attracting substantial investment due to the success of its weight-loss drug Mounjaro and its pill version, Foundayo. Yiu believes the company's innovation and financial capacity give it a competitive edge in a market with significant global potential. Eli Lilly shares have risen over 41 percent in the past year.

Jacob de Tusch-Lec, who has managed the Artemis Global Income fund for 16 years with nearly 800 percent in returns, favors Lion Finance Group, a UK-listed financial services company. De Tusch-Lec, a contrarian investor, focuses on companies that generate strong cash flow. Lion Finance Group, which has held shares since 2012, has seen significant growth in the past four years, driven by its subsidiary Bank of Georgia and expansion into Armenia. Despite acknowledging political risks associated with Georgia's location, de Tusch-Lec points to the country's EU-level banking regulations and growing economy. The company's recent promotion to the FTSE 100 is expected to increase demand for its shares, which have climbed 69 percent in the past year.

Alex Wright, manager of Fidelity Special Situations and Fidelity Special Values funds, highlights Frasers Group, a company majority-owned by Mike Ashley. Wright focuses on investments below the FTSE 100 index. He points to Frasers Group's business model, which leverages scale to acquire discounted stock, thereby boosting margins. The company's ownership of its retail sites also provides significant property backing. While Frasers Group shares have increased by 5.6 percent over the past year, Wright believes they are attractively priced given the company's holdings and strategic advantages.

Job Curtis, manager of the City of London Investment Trust for nearly 35 years, is optimistic about RELX, a provider of analytics and decision tools. Despite a share price drop of over 40 percent year-on-year due to concerns about artificial intelligence disruption, Curtis believes RELX is well-positioned to benefit from AI, which it already employs across its divisions. He highlights the company's proprietary analytics, algorithms, and data. Analysts forecast average annual earnings per share growth of 12 percent for the next four years, and the shares offer an attractive dividend yield of 2.8 percent.

Mike Seidenberg, manager of the Allianz Technology Trust, is excited about Bloom Energy, a U.S. energy company specializing in solid oxide fuel cell systems. Seidenberg sees Bloom Energy as favorably positioned due to the exploding growth in data centers fueled by AI, which requires reliable energy sources. The company's expertise in manufacturing environmentally friendly fuel cells capable of providing 24/7 energy supply addresses this robust demand. Bloom Energy's shares have surged 257 percent in the past six months.

Lastly, Nick Train of the Finsbury Growth & Income Trust identifies Fevertree, the premium drinks mixer brand, as a company with potential. Train notes that Fevertree invented and continues to dominate the premium mixer market, fending off numerous competitors. He is particularly optimistic about the brand's success in the U.S., driven by a partnership with North American drinks giant Molson Coors, which provides access to a vast distribution network. Despite a recent decline in share price, Train believes the Molson Coors tie-up could catalyze a significant recovery.